Prothena Corp Public (PRTA) Cash from Operations (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Cash from Operations of 28877000.0 for Q1 2026, up 154.11% year-over-year from 11363785.1 in Q1 2025, and up 223.87% quarter-over-quarter from 23312000.0 in Q4 2025.
Prothena Corp Public (PRTA) Cash from Operations (2012 - 2026) Analysis & Trends
Prothena Corp Public's Cash from Operations history runs 15 years deep, the most recent figure standing at 28877000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 154.11% year-over-year to 28877000.0; the TTM figure through Mar 2026 stood at 81340000.0 (up 37.6% YoY), while the FY2025 annual figure was 163580000.0, down 9.02% from the prior year.
- Cash from Operations for Q1 2026 stood at 28877000.0, up from 23312000.0 in the prior quarter.
- The five-year high for Cash from Operations was 28877000.0 in Q1 2026, with the low at 73051000.0 in Q1 2024.
- The 5-year median for Cash from Operations is 40565000.0 (2025), against an average of 31028235.29.
- The sharpest annual moves came in 2023 and 2026: Cash from Operations plunged 925.68% in 2023, then surged 154.11% in 2026.
- Prothena Corp Public's Cash from Operations stood at 4976000.0 in 2022, then slumped by 925.68% to 51038000.0 in 2023, then gained by 6.4% to 47772000.0 in 2024, then soared by 51.2% to 23312000.0 in 2025, then surged by 223.87% to 28877000.0 in 2026.
- Business Quant data shows PRTA's Cash from Operations at 28877000.0 in Q1 2026, 23312000.0 in Q4 2025, and 40565000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | -25.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.05 Mn |
| Jun 30, 2026 | -25.05 Mn |
| Mar 31, 2026 | 28.88 Mn |
| Mar 31, 2026 | 28.88 Mn |
| Dec 31, 2025 | -23.31 Mn |
| Dec 31, 2025 | -23.31 Mn |
| Sep 30, 2025 | -40.57 Mn |
| Sep 30, 2025 | -40.57 Mn |
| Jun 30, 2025 | -46.34 Mn |
| Jun 30, 2025 | -46.34 Mn |
| Mar 31, 2025 | -53.36 Mn |
| Mar 31, 2025 | -53.36 Mn |
| Dec 31, 2024 | -47.77 Mn |
| Dec 31, 2024 | -47.77 Mn |
| Sep 30, 2024 | -45.19 Mn |
| Sep 30, 2024 | -45.19 Mn |
| Jun 30, 2024 | 15.96 Mn |
| Jun 30, 2024 | 15.96 Mn |
| Mar 31, 2024 | -73.05 Mn |
| Mar 31, 2024 | -73.05 Mn |